You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 202321 - 202330 of 207699 results
  1. Validation of a Rodent Mutagenicity Assay

    SBC: Litron Laboratories Ltd            Topic: NIEHS

    DESCRIPTION (provided by applicant): Mutation to DNA is a primary mechanism by which cancers arise. These events have also been implicated in diseases such as atherosclerosis, and processes such as aging. Therefore, there is an important need for sensitive analytical methods that facilitate the study of mutagenesis, as well as the identification of chemical or physical agents that can mutate DNA. ...

    SBIR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  2. Validation of a Rodent Mutagenicity Assay

    SBC: Litron Laboratories Ltd            Topic: NIEHS

    DESCRIPTION (provided by applicant): Mutation to DNA is a primary mechanism by which cancers arise. These events have also been implicated in diseases such as atherosclerosis, and processes such as aging. Therefore, there is an important need for sensitiveanalytical methods that facilitate the study of mutagenesis, as well as the identification of chemical or physical agents that can mutate DNA. M ...

    SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  3. Validation of a RSK-inhibitor as a Novel Therapeutic for

    SBC: LUNA INNOVATIONS INCORPORATED            Topic: N/A

    DESCRIPTION (provided by applicant): The inactivation of the host immune response by Yersinia, the causative agent of the plague, is mediated by a family of six proteins called Yersinia outer proteins, or Yops, namely YopE, YopH, YopO, YopM, YopJ, and YopT. While the mechanisms of action of YopE, YopH, YopO, YopJ, and YopT are fairly well understood, the effects of YopM on the host response to Yer ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  4. Validation of artificial intelligence (AI) based software as medical device (SaMD) for retinopathy of prematurity (ROP)

    SBC: Siloam Vision, Inc.            Topic: NEI

    The purpose of this application is to perform the necessary clinical studies to seek regulatory approval for an artificial intelligence (AI) software as medical device (SaMD) for retinopathy of prematurity (ROP) diagnosis. ROP is a leading cause of childhood blindness worldwide, with approximately 50,000 babies going blind annually, most of which is preventable with accurate and timely diagnosis. ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  5. 5- Validation of Artificial Intelligence Technologies (VAIT)

    SBC: R-DEX SYSTEMS, INC.            Topic: N193A01

    As artificial intelligence (AI) becomes more ubiquitous in society and the DoD enterprise, trust in the results provided by AI is of paramount importance. To that end, R-DEX Systems introduces VAIT (Validation of Artificial Intelligence Technologies), a processing suite for assessing AI algorithms for validation, trust in the decision-making process, and robustness against adversarial attack. VAIT ...

    SBIR Phase I 2020 Department of DefenseNavy
  6. Validation of Artificial Intelligence Technologies (VAIT)

    SBC: R-DEX SYSTEMS, INC.            Topic: N193A01

    As Artificial Intelligence (AI) becomes more ubiquitous in society and the DoD enterprise, trust in the results provided by AI is of paramount importance. Therefore, R-DEX Systems (R-DEX) proposes to build on the successful Phase I to increase the TRL of the groundbreaking Validation of Artificial Intelligence Technologies (VAIT), an innovative processing suite for increasing trust in AI and Machi ...

    SBIR Phase II 2020 Department of DefenseNavy
  7. Validation of a salivary miRNA diagnostic test for autism spectrum disorder

    SBC: Quadrant Biosciences Inc.            Topic: 105

    Project Summary Abstract Autism spectrum disorder ASD is a continuum of neurodevelopmental characteristics that includes deficits in communication and social interaction as well as restrictive repetitive interests and behaviors ASD is an increasing public health concern with about in American children diagnosed with ASD in a fold increase in prevalence over the past years T ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  8. Validation of a salivary miRNA diagnostic test for autism spectrum disorder

    SBC: Quadrant Biosciences Inc.            Topic: 103

    Autism spectrum disorder (ASD) is a continuum of neurodevelopmental characteristics that includes deficits in communication and social interaction, as well as restrictive, repetitive interests and behaviors. ASD is an increasing public health concern, with about 1 in 45 American children diagnosed with ASD in 2014, a 10-fold increase in prevalence over the past 40 years. The effect of ASD on both ...

    STTR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  9. Validation of a Stroke Therapy Comprised of Synergistic Stem Cell-Derived Factors

    SBC: NeuroFx, Inc.            Topic: 101

    DESCRIPTION provided by applicant Stroke is the leading cause of disability in adults in the Western world Its socioeconomic impact is staggering Most stroke patients currently have no treatment option given that the only FDA approved stroke therapy intravenous tPA for treatment of thrombolysis must be administered within hours of stroke onset and only about of stroke patients present ...

    SBIR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health
  10. VALIDATION OF A TRANSGENIC MOUSE MUTATION MODEL

    SBC: LEVEN, INC.            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
US Flag An Official Website of the United States Government